Incontinence Interventions in Complex Wound Management

Course Overview

Course Outline

1. Introduction 
2. Overview of Incontinence 
3. Assessment 
   • Complex Wounds 
   • Pathophysiology 
   • Etiology 
   • Barriers to Wound Healing 
   • Incontinence-associated dermatitis 
4. The Overlap of Incontinence and Complex Wounds 
5. Management Strategies 
6. Case Studies and Practical Application 
7. Conclusion 

Accreditation Statement

Nursing CE Central LLC is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

In this course, we will discuss Incontinence Interventions in Complex Wound Management. It will take the average learner 180 minutes to complete and awards 3 contact hours of continuing education.

Course Outcomes

After completing this course, the learner will rate a 4 out of 5 on the Likert Scale for their ability to:

1. Identify different types of incontinence and their prevalence. 
2. Describe common types of complex wounds, their underlying pathophysiology, and the phases of wound healing. 
3. Explain the interrelationship between incontinence and wound healing. 
4. Apply behavioral, pharmacological, and product interventions for managing incontinence in the presence of a complex wound. 
5. Describe innovative treatments and emerging therapies in incontinence and wound care. 
6. Recognize the roles and responsibilities of interdisciplinary team members in managing incontinence and wounds. 

Target Audience

• Registered Nurses (RN)
• Advanced Practice Registered Nurses (APRN)
• Licensed Practical Nurses (LPN/LVN)

Requirement for Completion

1. Enrollment in the course by the learner
2. Read and learn all course materials
3. Complete the course evaluation
4. Attest and testify learning of the course materials

Accreditations + Approvals

Disclosure of Relevant Financial Relationships

Nursing CE Central nor any of the authors, planners, content experts, or any contributors have any relevant financial relationships with ineligible companies to disclose.